Shared Vision, Shared Progress: Swedish Delegates and ACTRIS Discuss the Future of CGT

We are honoured to have hosted Swedish delegates during their state visit to Singapore in November, which celebrated over 50 years of bilateral ties between the two countries and set the stage for stronger collaboration.

Our staff introduced ACTRIS's role as a national facility for clinical-scale manufacturing of cell therapy products in meeting the demand for both clinical trials and essential clinical services, as well as to spearhead the growth of Singapore's cell and gene therapy (CGT) ecosystem through workforce training and regulatory facilitation. We also shared about the role of Consortium for Clinical Research and Innovation, Singapore (CRIS)in supporting ACTRIS and five other programmes in developing strategies to facilitate synergistic collaborations to advance clinical research here and beyond.

Delegates toured our translational laboratories and engaged in insightful conversations discussing the CGT manufacturing landscape in Singapore and Sweden.

We enjoyed the knowledge exchange and shared about similarities in regulatory alignment, operational strategies, and collaborative approaches to meet current needs. It was a wonderful way to wrap up a fulfilling week.

You may view our LinkedIn post here.